The present study continues a 15 year longitudinal study of over 700 patients with Raynaud's syndrome. The present studies center around the relationship of platelet alpha 2 adrenoreceptor activity to the pathophysiology of the underlying Raynaud's condition, along with an evaluation of different vascular laboratory diagnostic tests and pharmacologic treatment programs.
Showing the most recent 10 out of 336 publications